Assignee
FOND TELETHON
IT·12 granted patents·15 pending applications·137 citations·filing 2004–2025
Top patents by PatentIndex Score
27 records- 0194US7517870B2Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularizationFOND TELETHON·Filed 2004·Granted Apr 14, 2009·108 cites·12 claims
- 0286US10494645B2Effective delivery of large genes by dual AAV vectorsFOND TELETHON·Filed 2014·Granted Dec 3, 2019·20 cites·19 claims
- 0378US12577560B2Gene vectorFOND TELETHON·Filed 2022·Granted Mar 17, 2026·0 cites·12 claims
- 0478US9951328B2Gene vectorFOND TELETHON·Filed 2017·Granted Apr 24, 2018·2 cites·12 claims
- 0575US9487766B2Therapeutic strategies to treat CNS pathology in mucopolysaccharidosesFOND TELETHON·Filed 2015·Granted Nov 8, 2016·3 cites·21 claims
- 0671US9193755B1TFEB variants and uses thereofFOND TELETHON·Filed 2015·Granted Nov 24, 2015·3 cites·8 claims
- 0767US2025367258A1IL-10-Producing CD4+ T Cells and Uses ThereofFOND TELETHON·Filed 2025·Application pending·0 cites
- 0867US2009192115A1Use of compounds that interfere with the hedgehog signaling pathway for the manufacture of a medicament for preventing, inhibiting, and/or reversing ocular diseases related with ocular neovascularizationFOND TELETHON·Filed 2009·Application pending·0 cites
- 0959US12285495B2Genome editing methods and constructsFOND TELETHON·Filed 2019·Granted Apr 29, 2025·0 cites·10 claims
- 1059US10369231B2MiR-204 and miR-211 and uses thereofFOND TELETHON·Filed 2014·Granted Aug 6, 2019·1 cites·15 claims
- 1158US2022389450A1Vector systemFOND TELETHON·Filed 2022·Application pending·0 cites
- 1255US2009010950A1Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereofFOND TELETHON·Filed 2008·Application pending·0 cites
- 1352US2011117058A1Method of treating genetic disordersFOND TELETHON·Filed 2009·Application pending·0 cites
- 1451US11098094B2Artificial DNA-binding proteins and uses thereofFOND TELETHON·Filed 2014·Granted Aug 24, 2021·0 cites·17 claims
- 1550US7740836B2Methods and compositions for recovering or improving visual functionFOND TELETHON·Filed 2006·Granted Jun 22, 2010·0 cites·6 claims
- 1650US2018050092A1Il-10-producing cd4+ t cells and uses thereofFOND TELETHON·Filed 2016·Application pending·0 cites
- 1747US2021371878A1Intein proteins and uses thereofFOND TELETHON·Filed 2019·Application pending·0 cites
- 1845US2019343929A1Combined therapy for mucopolysaccharidosis type vi (maroteaux-lamy-syndrome)FOND TELETHON·Filed 2017·Application pending·0 cites
- 1944US2015079051A1Tfeb gene therapy of alpha-1-antitrypsin deficiencyFOND TELETHON·Filed 2013·Application pending·0 cites
- 2043US2015147309A1Allosteric chaperones and uses thereofFOND TELETHON·Filed 2013·Application pending·0 cites
- 2140US2021277354A1Production of engineered dendritic cells and uses thereofFOND TELETHON·Filed 2019·Application pending·0 cites
- 2238US2015273016A1Gene therapy for glycogen storage diseasesFOND TELETHON·Filed 2013·Application pending·0 cites
- 2337US2016250221A1Inhibitors of fapp2 and uses thereofFOND TELETHON·Filed 2014·Application pending·0 cites
- 2433US2020230207A1Treatment of bone growth disordersFOND TELETHON·Filed 2016·Application pending·0 cites
- 2532US12410164B2Heterocyclic compounds and medical use thereofFOND TELETHON·Filed 2019·Granted Sep 9, 2025·0 cites·19 claims
- 2628US11096955B2Synthetic promoters and uses thereofFOND TELETHON·Filed 2017·Granted Aug 24, 2021·0 cites·25 claims
- 2728US2022160749A1Mir-181 inhibitors and uses thereofFOND TELETHON·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →